Dr. Gilberto Lopes, a medical oncologist at Centro Paulista de Oncologia, heads HCor Onco, the cancer center for Hospital do Coração, and leads the medical and scientific council for the Oncoclinicas group, a network of 28 clinics and 200 oncologists in Brazil. He was previously Senior Consultant Medical Oncologist, Program Leader for Health Economics and Outcomes Research and Assistant Director for Clinical Research at the Johns Hopkins Singapore International Medical Centre from 2006 to 2013; he holds concomitant positions as Assistant Professor of Oncology at the Johns Hopkins University in Baltimore, Maryland, as well as teaching faculty at the Perdana Graduate School of Medicine in Serdang, Malaysia.After obtaining his medical degree in Brazil, he undertook an internship, residency in internal medicine and fellowship in Hematology/Oncology at the University of Miami where he became Chief Medical Resident and Clinical Instructor.
Dr. Lopes has published more than 100 papers and book chapters in journals such as the Journal of Clinical Oncology, Cancer, Nature Reviews, Lancet Oncology and Health Affairs. In addition to delivering lectures around the world, he has been Principal or Co-Principal Investigator in more than 100 studies and clinical trials covering breast, gastrointestinal, genitourinary and thoracic cancers.
As an active member of the oncology community, Dr. Lopes has been an Invited Reviewer and member of the editorial board for several publications. He founded the Singapore Chapter of the “International Society for Pharmacoeconomics and Outcomes Research” and “Cancer Control in Low and Middle Income Countries”, an NGO. He was the Chairman for the Health Care committee at the American Chamber of Commerce in Singapore and a member of the executive committee for the Singapore Society of Oncology and a board member for the Chapter of Medical Oncologists at the Singapore Academy of Medicine. He is currently a committee member for the International Association for the Study of Lung Cancer (IASLC) and the American Society of Clinical Oncology (ASCO) and the international Associate Editor for ASCO University. He has also served as an expert for the International Atomic Energy Agency and the World Health Organization in official missions and advised governments, professional societies and industry on issues related to cancer control and treatment in low- and middle-income countries.
Health economics; Policy and Access to cancer drugs and treatment in low and middle income countries.